Euphorbia myrsinites Sap-Induced Phytodermatitis: A Prototype of Irritant Contact Dermatitis?


Journal

Dermatitis : contact, atopic, occupational, drug
ISSN: 2162-5220
Titre abrégé: Dermatitis
Pays: United States
ID NLM: 101207335

Informations de publication

Date de publication:
Historique:
pubmed: 5 3 2019
medline: 2 7 2019
entrez: 5 3 2019
Statut: ppublish

Résumé

A hallmark of Euphorbia myrsinites (EM), a member of the widespread perennial Euphorbia species, is the extrusion of a poisonous, latex-like sap irritant to the skin and eye after contact. The exact mechanisms underlying these effects have not been unraveled so far. The aims of the study were to allocate EM sap-induced phytodermatitis to irritant or allergic contact dermatitis (ACD) and to investigate mechanism(s) causing keratinocyte damage. Cutaneous effects of EM sap on healthy human skin were investigated by clinical scoring and reflectance confocal microscopy analyses and compared with ACD. In addition, the effects of sap exposure to keratinocytes were analyzed in vitro using histological analyses and flow cytometry. We report on 2 cases of EM sap-induced phytodermatitis. Patch testing with fresh EM sap induced dermatitis in 100% of the tested sites with a clinical course following a decrescendo pattern. Compared with ACD, the lesional phenotype was more severe and epidermal disruption was more pronounced. Exposure of human skin tissues and cultivated keratinocytes to EM sap in vitro resulted in a dose-dependent increase in keratinocyte apoptosis. The reported findings support the primarily toxic irritant nature of EM sap-induced phytodermatitis. The contribution of ingenol mebutate to (nontoxic) proinflammatory effects remains to be elucidated.

Sections du résumé

BACKGROUND BACKGROUND
A hallmark of Euphorbia myrsinites (EM), a member of the widespread perennial Euphorbia species, is the extrusion of a poisonous, latex-like sap irritant to the skin and eye after contact. The exact mechanisms underlying these effects have not been unraveled so far.
OBJECTIVES OBJECTIVE
The aims of the study were to allocate EM sap-induced phytodermatitis to irritant or allergic contact dermatitis (ACD) and to investigate mechanism(s) causing keratinocyte damage.
METHODS METHODS
Cutaneous effects of EM sap on healthy human skin were investigated by clinical scoring and reflectance confocal microscopy analyses and compared with ACD. In addition, the effects of sap exposure to keratinocytes were analyzed in vitro using histological analyses and flow cytometry.
CONCLUSIONS CONCLUSIONS
We report on 2 cases of EM sap-induced phytodermatitis. Patch testing with fresh EM sap induced dermatitis in 100% of the tested sites with a clinical course following a decrescendo pattern. Compared with ACD, the lesional phenotype was more severe and epidermal disruption was more pronounced. Exposure of human skin tissues and cultivated keratinocytes to EM sap in vitro resulted in a dose-dependent increase in keratinocyte apoptosis. The reported findings support the primarily toxic irritant nature of EM sap-induced phytodermatitis. The contribution of ingenol mebutate to (nontoxic) proinflammatory effects remains to be elucidated.

Identifiants

pubmed: 30829799
doi: 10.1097/DER.0000000000000454
pmc: PMC6420095
mid: EMS81109
doi:

Substances chimiques

Irritants 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-161

Subventions

Organisme : Austrian Science Fund FWF
ID : P 29619
Pays : Austria

Références

Eur J Dermatol. 1999 Mar;9(2):144-59
pubmed: 10066966
Arch Ophthalmol. 2000 Jan;118(1):13-6
pubmed: 10636407
Eur J Emerg Med. 2000 Jun;7(2):155-7
pubmed: 11132079
Clin Dermatol. 1992 Apr-Jun;10(2):157-65
pubmed: 1393949
Contact Dermatitis. 1977 Dec;3(6):289-92
pubmed: 146585
Contact Dermatitis. 2004 Jul;51(1):37-9
pubmed: 15291835
Allergy. 2004 Oct;59(10):1127-8
pubmed: 15355476
J Invest Dermatol. 2005 Feb;124(2):351-9
pubmed: 15675954
J Am Acad Dermatol. 2005 Nov;53(5):845
pubmed: 16243136
J Am Acad Dermatol. 2012 Mar;66(3):486-93
pubmed: 22055282
Chem Rev. 2014 Sep 10;114(17):8579-612
pubmed: 25036812
Contact Dermatitis. 2015 Oct;73(4):195-221
pubmed: 26179009
Dermatitis. 2016 Nov/Dec;27(6):372-381
pubmed: 27775975
Eur J Med Res. 2018 Sep 28;23(1):45
pubmed: 30266096
Clin Dermatol. 1986 Apr-Jun;4(2):36-45
pubmed: 3719513
Arch Dermatol. 1974 Jun;109(6):909-10
pubmed: 4830105
Am J Dis Child. 1979 Jan;133(1):28-9
pubmed: 760508
Contact Dermatitis. 1998 Oct;39(4):166-70
pubmed: 9817221

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH